Almay Stay Dry Hydro Solid Antiperspirant & Deodorant, Fragrance Free (2006 formulation) || Skin Deep: Cosmetic Safety Reviews

ALMAY STAY DRY HYDRO SOLID ANTIPERSPIRANT & DEODORANT, FRAGRANCE FREE (2006 FORMULATION)

last updated: 05/01/06 brand: Almay by Revlon Consumer Products Corporation

SCORE

low hazard (out of 10)

80%

data gap

BUY ONLINE/BETTER PRODUCTS

see online retailers

8% of antiperspirant/deodorants have lower concerns

COMPANY POLICIES

Compact for Safe Cosmetics
Non-signer: This company has not signed the Compact.

Animal Testing Policy
This company's animal testing policy is unknown.

Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.

Ingredients in this product are linked to:
	Cancer
	Developmental/reproductive toxicity
	Violations, restrictions & warnings
	Allergies/immunotoxicity
	Other concerns for ingredients used in this product: Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Contamination concerns

Ingredients from packaging: ACTIVE INGREDIENTS: ALUMINUM ZIRCONIUM TETRACHLORHYDREX 20% GLY. INACTIVE INGREDIENTS: WATER, DIPROPYLENE GLYCOL, HYDROXYSTEARIC ACID, PEG-14 DIMETHICONE, CYCLOMETHICONE, AGAROSE, ACETAMIDE MEA, DIMETHICONE CROSSPOLYMER, DIVINYLDIMETHICONE/DIMETHICONE COPOLYMER, C12-13 PARETH-23, C12-13 PARETH-3.

Directions from packaging: Apply to underarms only. Cap tightly after use.

Warnings from packaging: + For external use only. + Do not use on broken skin. + Stop use if rash or irritation occurs. + Ask a doctor before use if you have kidney disease. + Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

user reviews & comments

NEW! No reviews or ratings yet. Log in and be the first to leave a comment!

ingredients

	score	data gap	concerns
PEG-14 DIMETHICONE	4	75%	Organ system toxicity (non-reproductive), Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE)
ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLYCINE COMPLEX ALUMINUM ZIRCONIUM TETRACHLORHYDREX GLY (Active Ingredient)	1	91%	Organ system toxicity (non-reproductive)
CYCLOMETHICONE	2	83%	Persistence and bioaccumulation, Organ system toxicity (non-reproductive)
ACETAMIDE MEA	1	73%	Contamination concerns (ACETAMIDE MEA)
HYDROXYSTEARIC ACID	1	93%	none identified
C12-13 PARETH-23	1	86%	Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs)
C12-13 PARETH-3	1	86%	Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs)
DIPROPYLENE GLYCOL	1	84%	Irritation (skin, eyes, or lungs)
DIMETHICONE CROSSPOLYMER	0	100%	none identified
DIVINYLDIMETHICONE/ DIMETHICONE COPOLYMER	0	100%	none identified
AGAROSE	0	94%	none identified
WATER	0	0%	innocuous

Cancer*

*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show tumor formation at moderate doses		HYDROXYSTEARIC ACID

Violations, restrictions & warnings*

*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications		PEG-14 DIMETHICONE, ACETAMIDE MEA

Neurotoxicity*

*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show brain and nervous system effects at high doses		DIPROPYLENE GLYCOL
One or more animal studies show brain and nervous system effects at moderate doses		C12-13 PARETH-3, C12-13 PARETH-23

Persistence and bioaccumulation*

*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Not suspected to be persistent		C12-13 PARETH-3, C12-13 PARETH-23
Persistent, bioaccumulative in wildlife		CYCLOMETHICONE

Organ system toxicity (non-reproductive)*

*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient)		CYCLOMETHICONE, DIPROPYLENE GLYCOL, ACETAMIDE MEA
One or more animal studies show gastrointestinal effects at moderate doses (low dose studies may be unavailable for this ingredient)		C12-13 PARETH-3, C12-13 PARETH-23
Limited evidence of sense organ toxicity		PEG-14 DIMETHICONE, ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLYCINE COMPLEX

Ecotoxicology*

*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Suspected to be an environmental toxin		C12-13 PARETH-3, CYCLOMETHICONE, C12-13 PARETH-23

Irritation (skin, eyes, or lungs)*

*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Human any irritant - strong evidence	products for use around the eyes, on the skin, or may be aerosolized (airborne)	DIPROPYLENE GLYCOL
One or more animal studies show skin irritation at low doses		C12-13 PARETH-23, C12-13 PARETH-3
One or more animal studies show skin irritation at moderate doses		ACETAMIDE MEA, CYCLOMETHICONE

Data gaps*

*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product		PEG-14 DIMETHICONE, DIPROPYLENE GLYCOL
Not assessed for safety in cosmetics by industry panel		C12-13 PARETH-3
Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product		CYCLOMETHICONE
Not assessed for safety in cosmetics by industry panel		DIVINYLDIMETHICONE/ DIMETHICONE COPOLYMER, DIMETHICONE CROSSPOLYMER, AGAROSE, ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLYCINE COMPLEX, C12-13 PARETH-23

Biochemical or cellular level changes*

*This table includes all possible biochemical or cellular level changes concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.

type of concern	product conditions	ingredient(s)
One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood		CYCLOMETHICONE